ARTURO MD MOLINA, the Chief Medical Officer of $PTGX, sold 30,514 shares of the company on 03-13-2025 for an estimated $1,700,850. We received data on the trade from a recent SEC filing. This was a sale of approximately 26.7% of their shares of this class of stock. Following this trade, they now own 83,892 shares of this class of $PTGX stock.
$PTGX Insider Trading Activity
$PTGX insiders have traded $PTGX stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $PTGX stock by insiders over the last 6 months:
- SUNEEL GUPTA (Chief Development Officer) has made 0 purchases and 2 sales selling 122,628 shares for an estimated $5,635,429.
- DINESH V PH D PATEL (President and CEO) has made 0 purchases and 3 sales selling 105,359 shares for an estimated $4,885,355.
- ARTURO MD MOLINA (Chief Medical Officer) has made 0 purchases and 7 sales selling 67,589 shares for an estimated $3,193,360.
- ASIF ALI (Chief Financial Officer) has made 0 purchases and 3 sales selling 28,821 shares for an estimated $1,462,553.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PTGX Hedge Fund Activity
We have seen 132 institutional investors add shares of $PTGX stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,200,891 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $46,354,392
- DEEP TRACK CAPITAL, LP added 1,000,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $38,600,000
- MILLENNIUM MANAGEMENT LLC removed 958,283 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $43,122,735
- FAIRMOUNT FUNDS MANAGEMENT LLC removed 931,890 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $41,935,050
- WELLINGTON MANAGEMENT GROUP LLP added 909,998 shares (+3025.4%) to their portfolio in Q4 2024, for an estimated $35,125,922
- COWEN AND COMPANY, LLC removed 841,294 shares (-71.2%) from their portfolio in Q3 2024, for an estimated $37,858,230
- COLONY GROUP, LLC added 426,661 shares (+inf%) to their portfolio in Q3 2024, for an estimated $19,199,745
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PTGX Analyst Ratings
Wall Street analysts have issued reports on $PTGX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 03/11/2025
- Cowen & Co. issued a "Buy" rating on 10/14/2024
To track analyst ratings and price targets for $PTGX, check out Quiver Quantitative's $PTGX forecast page.
$PTGX Price Targets
Multiple analysts have issued price targets for $PTGX recently. We have seen 3 analysts offer price targets for $PTGX in the last 6 months, with a median target of $62.0.
Here are some recent targets:
- An analyst from BTIG set a target price of $73.0 on 03/03/2025
- Etzer Darout from BMO Capital set a target price of $62.0 on 12/05/2024
- Srikripa Devarakonda from Truist Financial set a target price of $60.0 on 11/22/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
